-
Publication Venue For
-
Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer..
40:5411-5416.
2020
-
Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma..
40:5245-5254.
2020
-
Textbook Outcomes Among Patients Undergoing Retroperitoneal Sarcoma Resection..
40:2107-2115.
2020
-
Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma..
39:2007-2014.
2019
-
Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma..
38:2875-2881.
2018
-
Update on Surgical Management of Small Bowel Neuroendocrine Tumors..
38:1267-1278.
2018
-
Neuroendocrine Neoplasms of the Appendix: A Review of the Literature..
38:601-611.
2018
-
Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians..
37:2649-2654.
2017
-
Non-Whipple Operations in the Management of Benign, Premalignant and Early Cancerous Duodenal Lesions..
37:1443-1452.
2017
-
Plasma Metabolites and Risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study..
37:719-725.
2017
-
The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma..
35:2465-2474.
2015
-
Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era..
34:2405-2411.
2014
-
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival..
33:3241-3245.
2013
-
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer..
32:4963-4969.
2012
-
A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors..
32:1689-1696.
2012
-
Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide..
31:4537-4543.
2011
-
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer..
31:1417-1420.
2011
-
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer..
31:255-261.
2011
-
Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human brain tumor models..
30:5037-5042.
2010
-
A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors..
30:1251-1256.
2010
-
A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver..
30:677-679.
2010
-
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors..
29:5149-5153.
2009